Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 30;22(7):3573.
doi: 10.3390/ijms22073573.

Biomimetic Chromatographic Studies Combined with the Computational Approach to Investigate the Ability of Triterpenoid Saponins of Plant Origin to Cross the Blood-Brain Barrier

Affiliations

Biomimetic Chromatographic Studies Combined with the Computational Approach to Investigate the Ability of Triterpenoid Saponins of Plant Origin to Cross the Blood-Brain Barrier

Katarzyna Stępnik. Int J Mol Sci. .

Abstract

Biomimetic (non-cell based in vitro) and computational (in silico) studies are commonly used as screening tests in laboratory practice in the first stages of an experiment on biologically active compounds (potential drugs) and constitute an important step in the research on the drug design process. The main aim of this study was to evaluate the ability of triterpenoid saponins of plant origin to cross the blood-brain barrier (BBB) using both computational methods, including QSAR methodology, and biomimetic chromatographic methods, i.e., High Performance Liquid Chromatography (HPLC) with Immobilized Artificial Membrane (IAM) and cholesterol (CHOL) stationary phases, as well as Bio-partitioning Micellar Chromatography (BMC). The tested compounds were as follows: arjunic acid (Terminalia arjuna), akebia saponin D (Akebia quinata), bacoside A (Bacopa monnieri) and platycodin D (Platycodon grandiflorum). The pharmacokinetic BBB parameters calculated in silico show that three of the four substances, i.e., arjunic acid, akebia saponin D, and bacoside A exhibit similar values of brain/plasma equilibration rate expressed as logPSFubrain (the average logPSFubrain: -5.03), whereas the logPSFubrain value for platycodin D is -9.0. Platycodin D also shows the highest value of the unbound fraction in the brain obtained using the examined compounds (0.98). In these studies, it was found out for the first time that the logarithm of the analyte-micelle association constant (logKMA) calculated based on Foley's equation can describe the passage of substances through the BBB. The most similar logBB values were obtained for hydrophilic platycodin D, applying both biomimetic and computational methods. All of the obtained logBB values and physicochemical parameters of the molecule indicate that platycodin D does not cross the BBB (the average logBB: -1.681), even though the in silico estimated value of the fraction unbound in plasma is relatively high (0.52). As far as it is known, this is the first paper that shows the applicability of biomimetic chromatographic methods in predicting the penetration of triterpenoid saponins through the BBB.

Keywords: IAM stationary phase; Quantitative Structure-Activity Relationship (QSAR); biomimetic studies; computational studies; micellar liquid chromatography; triterpenoid saponins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Logkw-BMC, logkw-IAM, and logkw-CHOL values obtained from the tested systems.
Figure 2
Figure 2
LogBB values obtained using the biomimetic and computational methods.

Similar articles

Cited by

References

    1. WHO . Dementia: A Public Health Priority. WHO; Geneva, Switzerland: 2012. World Health Organization and Alzheimer’s Disease International Report.
    1. Tao L., Zhang P., Qin C., Chen S.Y., Zhang C., Chen Z., Zhu F., Yang S.Y., We Y.Q., Chen Y.Z. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools. Adv. Drug Deliv. Rev. 2015;86:83–100. doi: 10.1016/j.addr.2015.03.014. - DOI - PubMed
    1. Etkins S., Waller C.L., Swaan P.W., Cruciani G., Wrighton S.A., Wikel J.H. Progress in predicting human ADME parameters in silico. J. Pharmacol. Toxicol. Methods. 2000;44:251–272. doi: 10.1016/S1056-8719(00)00109-X. - DOI - PubMed
    1. Etkins S., Ring B.J., Grace J., McRobie-Belle D.J., Wrighton S.A. Present and future in vitro approaches for drug metabolism. J. Pharmacol. Toxicol. Methods. 2000;44:313–324. doi: 10.1016/S1056-8719(00)00110-6. - DOI - PubMed
    1. Drews J. Drug discovery: A historical perspective. Science. 2000;287:1960–1964. doi: 10.1126/science.287.5460.1960. - DOI - PubMed

MeSH terms

LinkOut - more resources